Moderna CFO David Meline to retire, to be succeed by PerkinElmer’s James Mock


Moderna Inc. MRNA, -4.99% said Wednesday that Chief Financial Officer David Meline will retire, effective Sept. 6. Moderna shares fell 0.6% in premarket trading. The biotechnology company, which has one of the approved COVID-19 vaccines, said it has appointed James Mock as CFO, also starting Sept. 6. Mock was most recently CFO of PerkinElmer Inc. PKI, -0.86% for the past four years, after spending nearly 20 years in various financial oversight roles at General Electric Co. GE, +1.58% in the U.S. and abroad. “Jamey’s experience in scaling global businesses will ensure we continue to be well positioned for the future,” said Chief Executive Stéphane Bancel. Moderna’s stock has dropped 33.9% year to date through Tuesday, while the iShares Biotechnology ETF IBB, -1.36% has lost 12.9% and the S&P 500 SPX, +0.19% has declined 9.7%.

This article was originally published by Read the original article here.

Previous articleLivability: Nine U.S. towns worth visiting for their cool art scenes
Next articleTarget stock tumbles after big profit miss, gross margins pressured


Please enter your comment!
Please enter your name here